Login | Users Online: 1604  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us

    Article Cited by others


Statin Hepatotoxicity: Is it a Real Concern?

Sikka Pranav, Saxena K K, Kapoor Seema

Year : 2011| Volume: 12| Issue : 3 | Page no: 104-106

   This article has been cited by
1 Statins and risk of decompensation in hepatitis B virus-related and hepatitis C virus-related cirrhosis: Methodological issues
Chun-Yu Lin
Hepatology. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice
Hyunah Kim,Hyeseon Lee,Tong Min Kim,So Jung Yang,Seo Yeon Baik,Seung-Hwan Lee,Jae-Hyoung Cho,Hyunyong Lee,Hyeon Woo Yim,In Young Choi,Kun-Ho Yoon,Hun-Sung Kim
Cardiovascular Therapeutics. 2018; : e12324
[Pubmed]  [Google Scholar] [DOI]
3 Novel treatment options for portal hypertension
Philipp Schwabl,Wim Laleman
Gastroenterology Report. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Statin use is not associated with liver related mortality
Zahra Younoszai,Li Zheng,Maria Stepanova,Madeline Erario,Rebecca Cable,Zobair M. Younossi
Annals of Hepatology. 2014; 13(1): 84
[Pubmed]  [Google Scholar] [DOI]


Read this article